Literature DB >> 11232668

Nonerosive reflux disease--current concepts and dilemmas.

R Fass1, M B Fennerty, N Vakil.   

Abstract

Nonerosive reflux disease is defined as the presence of typical symptoms of gastroesophageal reflux disease caused by intraesophageal acid in the absence of visible esophageal mucosal injury at endoscopy. Recent studies demonstrate that it is a chronic disease with a significant impact on quality of life, and it is very common in primary care settings. Treatment with acid inhibitory agents is effective, and proton pump inhibitors are the most effective form of therapy.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11232668     DOI: 10.1111/j.1572-0241.2001.03511.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  72 in total

Review 1.  Brain meets gut: gastroesophageal reflux.

Authors:  R F Pfeiffer
Journal:  Clin Auton Res       Date:  2001-02       Impact factor: 4.435

Review 2.  Functional heartburn: the stimulus, the pain, and the brain.

Authors:  R Fass; G Tougas
Journal:  Gut       Date:  2002-12       Impact factor: 23.059

3.  A study on the efficacy of rebamipide for patients with proton pump inhibitor-refractory non-erosive reflux disease.

Authors:  Kyoichi Adachi; Kenji Furuta; Hiroto Miwa; Tadayuki Oshima; Masaharu Miki; Yoshinori Komazawa; Katsuhiko Iwakiri; Takahisa Furuta; Tomoyuki Koike; Tomohiko Shimatani; Yoshikazu Kinoshita
Journal:  Dig Dis Sci       Date:  2012-02-26       Impact factor: 3.199

4.  Validity of endoscopic classification of nonerosive reflux disease.

Authors:  Takashi Joh; Hiroto Miwa; Kazuhide Higuchi; Tomohiko Shimatani; Noriaki Manabe; Kyoichi Adachi; Tsuneya Wada; Makoto Sasaki; Yasuhiro Fujiwara; Michio Hongo; Tsutomu Chiba; Yoshikazu Kinoshita
Journal:  J Gastroenterol       Date:  2007-06-29       Impact factor: 7.527

5.  Prognostic influence of Barrett's oesophagus and Helicobacter pylori infection on healing of erosive gastro-oesophageal reflux disease (GORD) and symptom resolution in non-erosive GORD: report from the ProGORD study.

Authors:  P Malfertheiner; T Lind; S Willich; M Vieth; D Jaspersen; J Labenz; W Meyer-Sabellek; O Junghard; M Stolte
Journal:  Gut       Date:  2005-06       Impact factor: 23.059

6.  Symptom-histopathology relation in upper GI endoscopy.

Authors:  Emre Günay; Erkan Özkan; Hacı Mehmet Odabaşı; Hacı Hasan Abuoğlu; Cengiz Eriş; Mehmet Kamil Yıldız; Süleyman Atalay
Journal:  Ulus Cerrahi Derg       Date:  2013-09-01

7.  Critical role of stress in increased oesophageal mucosa permeability and dilated intercellular spaces.

Authors:  Ricard Farré; Rita De Vos; Karel Geboes; Kristine Verbecke; Pieter Vanden Berghe; Inge Depoortere; Kathleen Blondeau; Jan Tack; Daniel Sifrim
Journal:  Gut       Date:  2007-02-01       Impact factor: 23.059

8.  Functional heartburn, nonerosive reflux disease, and reflux esophagitis are all distinct conditions--a debate: pro.

Authors:  Tomás Navarro-Rodriguez; Ronnie Fass
Journal:  Curr Treat Options Gastroenterol       Date:  2007-08

9.  Outcome of nonerosive gastro-esophageal reflux disease patients with pathological acid exposure.

Authors:  Fabio Pace; Stefano Pallotta; Gianpiero Manes; Annalisa de Leone; Patrizia Zentilin; Luigi Russo; Vincenzo Savarino; Matteo Neri; Enzo Grossi; Rosario Cuomo
Journal:  World J Gastroenterol       Date:  2009-12-07       Impact factor: 5.742

Review 10.  Current perspectives on the diagnosis and treatment of functional esophageal disorders.

Authors:  Roy Dekel; Ronnie Fass
Journal:  Curr Gastroenterol Rep       Date:  2003-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.